Challenges in genetic screening for inherited endocrinopathy affecting the thyroid, parathyroid and adrenal glands in Singapore.
endocrine
endocrinology
endocrinopathy
general surgery
genetic
oncology
quality of life
syndromes
Journal
Annals of the Academy of Medicine, Singapore
ISSN: 2972-4066
Titre abrégé: Ann Acad Med Singap
Pays: Singapore
ID NLM: 7503289
Informations de publication
Date de publication:
29 Apr 2024
29 Apr 2024
Historique:
medline:
26
6
2024
pubmed:
26
6
2024
entrez:
26
6
2024
Statut:
epublish
Résumé
Significant progress has been made in the understand-ing of many human diseases, especially cancers, which has contributed to improved and increased survival. The Human Genome Project and The Cancer Genome Atlas project brought about a new era, with an understanding of inherited diseases at a molecular level, which subsequently facilitated the option of precision medicine. Precision medicine has helped tailor treatment decisions at an individual level, for instance in terms of surgical treatments or targeted therapies in advanced diseases. Despite the increasing advances in genetic-lead precision medicine, this has not translated into increasing uptake among patients. Reasons for this may be potential knowledge gaps among clinicians; on reasons for poor uptake of genetic testing such as for cultural, religious or personal beliefs; and on financial implications such as lack of support from insurance companies. In this review, we look at the current scenario of genetic screening for common inherited endocrine conditions affecting the thyroid, parathyroid and adrenal glands in Singapore, and the implications associated with it.
Identifiants
pubmed: 38920182
doi: 10.47102/annals-acadmedsg.202368
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
253-263Déclaration de conflit d'intérêts
No conflict of interests to declare.